Mitsubishi Gas Chemical Company,Inc. FY2027 Q1 Earnings Report

Quick View

Executive Summary

Operating income grew more than 2.5-fold due to price pass-through and an improved product mix, resulting in higher revenue and earnings as well as a structural improvement in profit margins. Revenue was ¥2237.0B (+25.7% YoY), operating income was ¥278.4B (+153.5%), ordinary income was ¥291.9B (+111.0%), and net income attributable to owners of the parent was ¥183.3B (+118.1%). The gross profit margin improved from 22.1% to 25.2%, while improved profitability in both the Functional Chemicals and Green Energy & Chemicals segments lifted the company-wide profit margin.

Factors Driving Earnings Fluctuations

【Revenue】Revenue was ¥2237.0B, up +25.7% YoY. By segment, the Functional Chemicals Business Division remained the largest, at ¥1228.3B (54.9% of total revenue, YoY +12.8%), while the Green Energy & Chemicals Business Division posted substantial revenue growth to ¥998.0B (44.6% of total revenue, YoY +46.2%). Other businesses contributed ¥45.6B (YoY +24.5%), complementing the overall performance.

【Profit and Loss】Operating income was ¥278.4B (+153.5%), and the operating margin expanded to 12.4% (equivalent to 6.2% in the previous year). The gross profit margin improved to 25.2% (+3.1pt YoY) due to a decline in the cost-of-sales ratio, while the SG&A ratio declined to 12.8%, resulting in operating leverage. Non-operating income of ¥31.5B, including dividend income of ¥10.4B and foreign exchange gains of ¥5.5B, further lifted ordinary income, although its scale was limited to approximately 11% of operating income. Extraordinary items resulted in a net loss of ¥3.8B, including impairment losses of ¥2.7B and business restructuring expenses of ¥1.8B, with a limited impact. Overall, the results can be characterized by higher revenue and earnings.

Segment Analysis

The Functional Chemicals Business Division generated segment profit of ¥179.1B (¥99.5B in the previous year), with a profit margin of 14.6% (9.1% in the previous year), making it the largest driver of consolidated earnings. The Green Energy & Chemicals Business Division generated segment profit of ¥116.4B (¥39.0B in the previous year), with a profit margin of 11.7% (5.7% in the previous year), representing a substantial improvement; its revenue growth rate (+46.2%) was also the highest of the two divisions. Other businesses turned profitable, posting segment profit of ¥3.9B (a loss of ¥2.5B in the previous year). Both core segments achieved improved profitability in addition to revenue growth, confirming the effects of pricing policies and changes in product mix at the company-wide level. The structure in which the Functional Chemicals segment’s profit margin exceeds that of Green Energy & Chemicals has continued, and Functional Chemicals remains the center of the earnings structure.

Key Financial Indicators

【Profitability】The operating margin was 12.4% and the net profit margin was 8.2% (net income attributable to owners of the parent of ¥183.3B was used for net income), both representing substantial improvements from the previous year. ROE was 3.0%, remaining at a level calculated based on quarterly net income of ¥183.3B and an average level of equity. 【Cash Quality】Accounts receivable increased to ¥1665.1B (+11.4% YoY), while inventories rose to ¥1235.2B (+12.2%), reflecting higher demand but potentially placing pressure on cash generation through an expansion in working capital. 【Investment Efficiency】Revenue of ¥2237.0B against total assets of ¥11592.2B indicates that asset turnover remained low, leaving room for improvement in asset efficiency. 【Financial Soundness】The equity ratio was 60.3%, and liquidity was high, with current assets of ¥4836.4B against current liabilities of ¥2529.8B. The balance between long- and short-term funding was also sound, with long-term borrowings of ¥1026.4B and bonds of ¥550.0B, indicating a healthy financial foundation.

Cash Flow Analysis

Although operating cash flow (OCF) was not disclosed, the movement of funds can be inferred from changes in the balance sheet. Accounts receivable increased by ¥169.9B from the previous year, and inventories increased by ¥134.8B, indicating an accumulation of working capital to meet higher demand. Accounts payable also increased by ¥115.1B, partially offsetting the increase, but cash and deposits stood at ¥665.4B, down ¥24.3B from the previous year, suggesting that the increase in working capital may have placed pressure on cash on hand. Property, plant and equipment increased by ¥52.0B, indicating limited capital investment, while investment securities increased by ¥94.1B, including the impact of valuation differences. Overall, the data indicates that the expansion of working capital is restraining the pace of cash generation relative to earnings growth.

Quality of Earnings

Profit growth during the current period was primarily driven by recurring business activities, and the overall quality of earnings was favorable. Non-operating income of ¥31.5B consisted of dividend income of ¥10.4B, foreign exchange gains of ¥5.5B, share of profit or loss of ¥5.1B, and other items, representing a limited contribution of approximately 11% relative to operating income. Extraordinary items resulted in a net loss of ¥3.8B, as extraordinary gains of ¥8.7B, including gains on the sale of investment securities of ¥5.8B, were offset by extraordinary losses of ¥12.4B, including impairment losses of ¥2.7B and business restructuring expenses of ¥1.8B. The gap between ordinary income of ¥291.9B and net income attributable to owners of the parent of ¥183.3B reflects the tax burden—income taxes of ¥80.7B and an effective tax rate of approximately 28%—as well as net income attributable to non-controlling interests of ¥24.1B; both are within reasonable ranges. Meanwhile, increases in accounts receivable and inventories are factors that create a gap between accounting earnings and cash flow, requiring close monitoring of future cash conversion.

Earnings Forecast and Guidance

Progress against the full-year forecast was 26.0% for revenue (¥2237.0B/¥8600.0B), 39.2% for operating income (¥278.4B/¥710.0B), and 36.9% for ordinary income (¥291.9B/¥790.0B), exceeding the 25% benchmark for simple quarterly progress. In particular, the fact that progress in operating and ordinary income substantially exceeded revenue progress indicates that margin improvement from price pass-through and mix enhancement emerged earlier than expected in the first half. The company revised its earnings forecast during the current quarter, and the results may reflect an upward revision to the full-year outlook. Going forward, the focus will be on demand trends in the second half and the risk of a reversal in raw material and fuel costs.

Shareholder Returns

The full-year dividend forecast is ¥110 per share, implying a payout ratio of approximately 39% based on the company’s planned EPS of ¥282.04. No revision was made to the dividend forecast, and the company plans to increase the dividend from ¥50 in the previous fiscal year (a reference figure before combining the interim and year-end dividends). Progress in quarterly net income attributable to owners of the parent (33.3%) has been solid, and with financial leverage also low, there appears to be no obstacle to securing funds for dividends. No information regarding share buybacks has been identified in the disclosed data.

Risk Factors

1. Deterioration in working capital efficiency: Accounts receivable of ¥1665.1B (+11.4% YoY) and inventories of ¥1235.2B (+12.2%) have accumulated. If demand slows, this could lead to inventory valuation losses and increased funding requirements.

2. Segment concentration: The Functional Chemicals Business Division accounts for 54.9% of revenue, creating a structure in which supply-demand fluctuations and pricing trends in this division have a significant impact on company-wide performance.

3. Presence of non-recurring gains and losses: The company recorded impairment losses of ¥2.7B and business restructuring expenses of ¥1.8B as extraordinary losses. Changes in the business environment and asset values may continue to create non-recurring earnings factors.

Industry Benchmark (Reference; Company Research)

Industry Benchmark (manufacturing)

Profitability and Returns

The company’s profitability exceeds the industry median and ranks at a high level within the manufacturing industry.

Growth and Capital Efficiency

The revenue growth rate substantially exceeds the industry median, indicating an outstanding growth pace within the industry.

※Source: Company research

Key Takeaways from the Earnings Results

1. The gross profit margin improved by +3.1pt YoY, while the operating margin also improved substantially. The contribution of price pass-through and changes in product mix to the normalization of the earnings structure is a key takeaway from the results.

2. Full-year progress exceeded the quarterly even-progress benchmark (25%) on an operating and ordinary income basis, confirming that earnings improvement was realized earlier than expected in the first half.

3. Accounts receivable and inventories continue to increase. The fact that working capital is expanding faster than earnings is a structural change that should be monitored when assessing cash flow quality.

Theoretical Share Price (Reference Value)

This is a mechanically calculated reference range based solely on publicly disclosed data using a residual income model (Ohlson-type model with an explicit five-year fade). It is not a forecast of the market share price or a recommendation of any specific investment action.

Sensitivity: ¥3,405–¥3,603 at ±1% for the cost of equity, and ¥3,499–¥3,503 at ±0.1 for ω.

Notes:

• Because forecast ROE is below the cost of equity, the theoretical value is below book value per share.
• Net assets as of the end of the quarter are used, resulting in a timing difference relative to the full-year forecast.
• Because net assets include non-controlling interests, the theoretical value may be calculated at a somewhat high level.

(Calculation model: Residual Income Model / Interest Rate Reference Month: 2026-07 / This value does not forecast or guarantee the future share price)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not recommend investment in any specific issue. Industry benchmarks are reference information compiled by the company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting a professional as necessary.

---End of Report---